EGF c.478_479delinsGT ;(p.P160V)

Variant ID: 4-110864560-CC-GT

NM_001963.4(EGF):c.478_479delinsGT;(p.P160V)

This variant was identified in 1 publication

View GRCh38 version.




Publications:


Lessons learned from the development of an abl tyrosine kinase inhibitor for chronic myelogenous leukemia.

The Journal Of Clinical Investigation
Druker, B J BJ; Lydon, N B NB
Publication Date: 2000-01

Variant appearance in text: EGF: p160v
PubMed Link: 10619854
Variant Present in the following documents:
  • Main text
View BVdb publication page